VA Announces National Trial Testing Semaglutide for Alcohol-Use Disorder
VA has announced a Phase 3 semaglutide trial for veterans with alcohol-use disorder, but the drug remains investigational and recruitment details differ.
VA has announced a Phase 3 semaglutide trial for veterans with alcohol-use disorder, but the drug remains investigational and recruitment details differ.
The WHO says a rare Ebola outbreak in the Democratic Republic of the Congo and Uganda requires clinical trials, stronger surveillance and more funding.
The FDA proposed withdrawing U.S. approval of TAVNEOS, a treatment for adults with severe ANCA-associated vasculitis, after identifying manipulated pivotal-trial results, undisclosed analyses and serious liver injuries.